Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Multiple Myeloma Patient Registry

ClinicalTrials.gov ID: NCT03180853

Public ClinicalTrials.gov record NCT03180853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to document the participants characteristics, disease burden, and clinical management of participants in the United States who are treated for relapsed multiple myeloma in routine medical practice with a treatment strategies that include a proteasome inhibitor (PI) and/or immunomodulatory drug (IMiD) used either as monotherapy or combination therapy with other treatments.

Study identification

NCT ID
NCT03180853
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Janssen Scientific Affairs, LLC
Industry
Enrollment
85 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2017 (Actual)
Primary completion
Apr 6, 2018 (Actual)
Completion
Apr 6, 2018 (Actual)
Last update posted
Feb 3, 2025

2017 – 2018

United States locations

U.S. sites
69
U.S. states
25
U.S. cities
66
Facility City State ZIP Site status
Arizona Oncology Associates, PC - HAL Phoenix Arizona 85016 —
Mercy Research Fort Smith Arkansas 72903-4100 —
Genesis Cancer Center Hot Springs Arkansas 71913 —
St. Bernard's Medical Center Jonesboro Arkansas 72401 —
CARTI Little Rock Arkansas 72205 —
Facey Medical Group Mission Hills California 91345 —
North County Oncology Oceanside California 92056 —
Ventura County Hematology Oncology Specialists Oxnard California 93030 —
James R. Berenson, MD Inc. West Hollywood California 90069 —
PIH Health Hospital Whittier California 90602 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
University Cancer Institute (UCI) Boynton Beach Florida 33426 —
Southeast Florida Hematology Oncology Group Fort Lauderdale Florida 33308 —
Mayo Clinic in Florida Jacksonville Florida 32224 —
Cancer Specialists of North Florida Jacksonville Florida 32256 —
Watson Clinic Llp Lakeland Florida 33805 —
Ocala Oncology Center Ocala Florida 34471 —
Piedmont Cancer Institute Atlanta Georgia 30318 —
Augusta University Augusta Georgia 30912 —
Gwinnett Hospital System, Inc Lawrenceville Georgia 30046 —
Nancy N. and J.C. Lewis Cancer & Research Pavillion -St. Josephs Candler Health System Savannah Georgia 31405 —
Ingalls Memorial Hospital Cancer Research Center Harvey Illinois 60426 —
Orchard Healthcare Research Skokie Illinois 60077 —
Baptist Healthcare Systems, Inc. d/b/a Baptist Health Floyd New Albany Indiana 47150 —
Physicians' Clinic of Iowa, P.C at PCI Main Building Cedar Rapids Iowa 52403 —
Commonwealth Hematology-Oncology, P.C. Danville Kentucky 40422 —
Hardin Memorial Hospital Elizabethtown Kentucky 42701 —
Kentucky Cancer Care Hazard Kentucky 41701 —
Oncology Associates of West Kentucky Paducah Kentucky 42003 —
West Kentucky Hematology-Oncology Paducah Kentucky 42003 —
Pontchartrain Cancer Center Covington Louisiana 70433 —
Tulane University Hospital & Clinics New Orleans Louisiana 70112 —
Mercy Medical Center Baltimore Maryland 21202 —
Meritus Center for Clinical Research Hagerstown Maryland 21742 —
Reliant Medical Group, Inc. Worcester Massachusetts 01608 —
Henry Ford Health System Detroit Michigan 48202 —
MidMichigan Health Cancer Center Midland Michigan 48640 —
Providence Cancer Center Southfield Michigan 48075 —
St. Luke's Speciality Clinic Duluth Minnesota 55802 —
Singing River Health System Pascagoula Mississippi 39581 —
Trinitas Comprehensive Cancer Center Elizabeth New Jersey 07207 —
Southern Oncology Hematology Associates Williamstown New Jersey 08360 —
North Shore Hematology Oncology Associates, P.C. East Setauket New York 11733 —
Hudson Valley Hematology Oncology Associates Poughkeepsie New York 12601 —
Community Health Network Rochester New York 14620 —
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center Columbus Ohio 43219 —
Dayton Physicians, LLC Kettering Ohio 45409 —
Good Samaritan Hospital Corvallis Corvallis Oregon 97330 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Lehigh Valley Health network (Oncology) Bethlehem Pennsylvania 18015 —
Hematology and Oncology Associates of NEPA Dunmore Pennsylvania 18512 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Aria Health- Torresdale Philadelphia Pennsylvania 19114 —
Charleston Cancer Center Charleston South Carolina 29406 —
Carolina Blood and Cancer Care Rock Hill South Carolina 29732 —
Wellmont Blue Ridge Medical Specialists Bristol Tennessee 37620 —
Jackson Madison County General Hospital Jacksonville Tennessee 38301 —
Texas Oncology P A Arlington Texas 76012 —
Texas Oncology P A Beaumont Texas 77702-1449 —
Texas Oncology P A Denton Texas 76210 —
Texas Oncology P A Flower Mound Texas 75028 —
Texas Oncology-Memorial City Houston Texas 77024 —
Texas Oncology P A Paris Texas 75460 —
Texas Oncology P A Plano Texas 75075 —
Texas Oncology P A Tyler Texas 75702 —
Texas Oncology P A Waco Texas 76712 —
Texas Oncology P A Webster Texas 77598 —
Texas Oncology P A Wichita Falls Texas 76310 —
Kadlec Clinic Hematology & Oncology Kennewick Washington 99336 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03180853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2025 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03180853 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →